
ESC 2026 marked a turning point — GLP-1s earn their first formal heart failure guideline recommendation and become a cardiometabolic platform.
Discover how AI-simulated roleplay empowers pharma field teams to win HCP conversations with clinical fluency, confidence, and real-world readiness.